News

Scientists have identified a protein, called GPR68, that senses blood flow and tells small blood vessels called arterioles when to dilate. 

Researchers found a transcription factor protein called Runx3 puts dividing T cells on track to becoming memory T cells. 

“There is a dire need for the development of new, effective and safe therapies against chronic lymphocytic leukemia.”

A new discovery by Scripps Research scientists may offer insight into treating blood disorders such as sickle cell anemia.

Scripps Research scientists uncover role of key protein in genetic disease Charcot-Marie-Tooth with public support.

Balzan Prize and Coley Award goes to former Scripps Research postdocs.

Influenza kills thousands of Americans each year. Now a new study shows how we could improve flu vaccines.

"We need to know what is happening in the brain so that we can develop more efficient therapies."

This is the 19th year in a row that the program has earned top ten honors.

A surprising common mutation may have evolved to protect humans from malaria.

Researchers have discovered a pathway in cells that promotes mitochondrial function during times of stress, a response that can guard against disease as we age.

Calibr has now identified and repurposed an FDA-approved drug, clofazimine, used for decades to treat leprosy, as a potential new treatment for cryptosporidiosis.

"It’s already clear that this method opens the door to creating new types of compounds and new types of bonds."

"This study provides guidance for developing therapeutics," says Xiang-Lei Yang, PhD, TSRI professor and senior author of the study.

The new study offers an explanation for why neurons die off in the first place.

More than 27 million people live with osteoarthritis, and it turns out, elite racing and jumping horses do, too.

The breakthrough may expand research on the roles of glycans in human diseases, including cancers.

By combing through thousands of human genome sequences, scientists have identified regions of our DNA that rarely change.

Scientists are finding new clues about how proteins interact with each other.

"These results lay the groundwork for the next steps toward FDA approval."

Researchers have developed a quick and easy way to simultaneously modify dozens of drugs or molecules to improve their disease-fighting properties.

Scientists at The Scripps Research Institute are leading the charge to make scientific data more accessible.

Data from individual patients could hold clues to stopping Ebola virus and related killers.